Jones Financial Companies Lllp Pfizer Inc Transaction History

Jones Financial Companies Lllp

$97.4 Billion
Q3 2024

A detailed history of Jones Financial Companies Lllp transactions in Pfizer Inc stock. As of the latest transaction made, Jones Financial Companies Lllp holds 1,340,057 shares of PFE stock, worth $35.8 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,340,057

Previous 712,377 88.11%

Holding current value

$35.8 Million

Previous $19.9 Million 94.57%

% of portfolio

0.04%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$27.7 - $31.39 $17.4 Million - $19.7 Million	627,680 Added 88.11%	1,340,057 $38.8 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $6.79 Million - $7.95 Million	268,623 Added 60.53%	712,377 $19.9 Million
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $2.46 Million - $2.83 Million	95,130 Added 27.29%	443,754 $12.3 Million
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $787,845 - $1.02 Million	-30,151 Reduced 7.96%	348,624 $10 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $217,313 - $254,017	6,772 Added 1.82%	378,775 $12.6 Million
Q2 2023 Aug 09, 2023	BUY	$36.12 - $41.79 $19,685 - $22,775	545 Added 0.15%	372,003 $13.6 Million
Q1 2023 May 11, 2023	BUY	$39.39 - $51.28 $336,390 - $437,931	8,540 Added 2.35%	371,458 $15.2 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $148,504 - $193,856	3,557 Added 0.99%	362,918 $18.6 Million
Q3 2022 Nov 03, 2022	SELL	$43.76 - $53.42 $300,762 - $367,155	-6,873 Reduced 1.88%	359,361 $15.7 Million
Q2 2022 Aug 08, 2022	SELL	$46.53 - $55.17 $302,258 - $358,384	-6,496 Reduced 1.74%	366,234 $19.2 Million
Q1 2022 May 02, 2022	SELL	$45.75 - $56.69 $567,345 - $703,012	-12,401 Reduced 3.22%	372,730 $19.3 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $738,429 - $1.09 Million	17,871 Added 4.87%	385,131 $22.7 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $19,782 - $25,411	-504 Reduced 0.14%	367,260 $15.8 Million
Q2 2021 Aug 12, 2021	BUY	$35.91 - $40.68 $339,924 - $385,076	9,466 Added 2.64%	367,764 $14.4 Million
Q1 2021 Apr 30, 2021	BUY	$33.49 - $37.77 $234,597 - $264,578	7,005 Added 1.99%	358,298 $13 Million
Q4 2020 Feb 08, 2021	BUY	$33.47 - $42.56 $425,470 - $541,022	12,712 Added 3.75%	351,293 $12.9 Million
Q3 2020 Oct 29, 2020	BUY	$31.75 - $37.25 $387,159 - $454,226	12,194 Added 3.74%	338,581 $12.4 Million
Q2 2020 Jul 31, 2020	SELL	$30.12 - $36.54 $578,755 - $702,116	-19,215 Reduced 5.56%	326,387 $10.7 Million
Q1 2020 May 01, 2020	BUY	$27.03 - $38.62 $47,221 - $67,469	1,747 Added 0.51%	345,602 $11.3 Million
Q4 2019 Jan 21, 2020	BUY	$32.92 - $37.36 $50,367 - $57,160	1,530 Added 0.45%	343,855 $13.5 Million
Q3 2019 Oct 31, 2019	BUY	$32.49 - $42.13 $115,274 - $149,477	3,548 Added 1.05%	342,325 $12.3 Million
Q2 2019 Aug 02, 2019	BUY	$36.98 - $41.52 $391,470 - $439,530	10,586 Added 3.23%	338,777 $14.7 Million
Q1 2019 May 03, 2019	SELL	$37.5 - $41.2 $63,187 - $69,422	-1,685 Reduced 0.51%	328,191 $13.9 Million
Q4 2018 Feb 11, 2019	SELL	$38.47 - $43.86 $1.45 Million - $1.66 Million	-37,756 Reduced 10.27%	329,876 $14.4 Million
Q3 2018 Nov 08, 2018	SELL	$34.47 - $41.81 $104,650 - $126,935	-3,036 Reduced 0.82%	367,632 $16.2 Million
Q2 2018 Aug 08, 2018	SELL	$32.98 - $35.16 $165,427 - $176,362	-5,016 Reduced 1.34%	370,668 $13.4 Million
Q1 2018 May 11, 2018	SELL	$31.91 - $37.02 $264,023 - $306,303	-8,274 Reduced 2.15%	375,684 $13.3 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $67,817 - $71,956	2,039 Added 0.53%	383,958 $13.9 Million
Q3 2017 Nov 14, 2017	SELL	$31.0 - $34.15 $358,639 - $395,081	-11,569 Reduced 2.94%	381,919 $13.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	393,488	393,488 $13.2 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jones Financial Companies Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Jones Financial Companies Lllp with notifications on news.

Account

Jones Financial Companies Lllp Pfizer Inc Transaction History